<MedlineCitation Status="Completed">
<MedlineID>10011900</MedlineID>
<PMID>217502</PMID>
<DateCreated>
<Year>1979</Year>
<Month>05</Month>
<Day>26</Day>
</DateCreated>
<DateCompleted>
<Year>1979</Year>
<Month>05</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article>
<Journal>
<ISSN>0006-8993</ISSN>
<JournalIssue>
<Volume>166</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1979</Year>
<Month>Apr</Month>
<Day>20</Day>
</PubDate>
</JournalIssue>
</Journal>
<ArticleTitle>Taurine: stimulation of pineal N-acetyltransferase activity and melatonin production via a beta-adrenergic mechanism.</ArticleTitle>
<Pagination>
<MedlinePgn>65-74</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Pineal glands convert [3H]tryptophan to [3H]N-acetylserotonin and [3H]melatonin in organ culture. Taurine treatment increases the rate of production of these compounds 40- and 25-fold respectively by stimulating the activity of N-acetyltransferase. This stimulation is blocked stereospecifically by L-propranolol, indicating that taurine is probably acting via beta-adrenergic receptors. Taurine is active in stimulating N-acetyltransferase activity in denervated glands, suggesting that it might interact directly with the beta-adrenergic receptor, and not by causing the release of norepinephrine from nerve terminals.</AbstractText>
</Abstract>
<AuthorList>
<Author>
<LastName>Wheler</LastName>
<ForeName>G H</ForeName>
<Initials>GH</Initials>
</Author>
<Author>
<LastName>Weller</LastName>
<ForeName>J L</ForeName>
<Initials>JL</Initials>
</Author>
<Author>
<LastName>Klein</LastName>
<ForeName>D C</ForeName>
<Initials>DC</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>NETHERLANDS</Country>
<MedlineTA>Brain Res</MedlineTA>
<NlmUniqueID>0045503</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Receptors, Adrenergic</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Receptors, Adrenergic, beta</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>107-35-7</RegistryNumber>
<NameOfSubstance>Taurine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>51-41-2</RegistryNumber>
<NameOfSubstance>Norepinephrine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>525-66-6</RegistryNumber>
<NameOfSubstance>Propranolol</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>73-22-3</RegistryNumber>
<NameOfSubstance>Tryptophan</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>73-31-4</RegistryNumber>
<NameOfSubstance>Melatonin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.1.1.4</RegistryNumber>
<NameOfSubstance>Acetylserotonin N-Methyltransferase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.3.1.</RegistryNumber>
<NameOfSubstance>Acetyltransferases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName>Acetylserotonin N-Methyltransferase</DescriptorName>
<QualifierName>metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Acetyltransferases</DescriptorName>
<QualifierName MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Animal</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Denervation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Melatonin</DescriptorName>
<QualifierName MajorTopicYN="Y">biosynthesis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Norepinephrine</DescriptorName>
<QualifierName>pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Pineal Body</DescriptorName>
<QualifierName MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Propranolol</DescriptorName>
<QualifierName>pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Receptors, Adrenergic</DescriptorName>
<QualifierName MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Receptors, Adrenergic, beta</DescriptorName>
<QualifierName MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Support, U.S. Gov't, P.H.S.</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Taurine</DescriptorName>
<QualifierName MajorTopicYN="Y">pharmacology</QualifierName>
<QualifierName>physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Tissue Culture</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Tryptophan</DescriptorName>
<QualifierName>metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
